## Heme Synthesis Pathway and Regulation ### Overview of Heme Biosynthesis Heme synthesis is a tightly regulated 8-step pathway occurring primarily in mitochondria. The pathway begins with condensation of succinyl-CoA and glycine and culminates in the insertion of iron into protoporphyrin IX. ### Analysis of Each Statement | Statement | Accuracy | Notes | |-----------|----------|-------| | ALA synthase inhibition by heme | ✓ Correct | Rate-limiting enzyme; heme provides negative feedback | | PBGD condensation reaction | ✓ Correct | Catalyzes 4 PBG → hydroxymethylbilane (first tetrapyrrole) | | Ferrochelatase mechanism | ✗ **INCORRECT** | Ferrochelatase is **inhibited** by iron, not activated; this is a regulatory mechanism | | ALA synthesis location and substrates | ✓ Correct | Mitochondrial matrix; requires pyridoxal phosphate (B₆) as cofactor | ### Key Regulatory Mechanisms **Key Point:** Ferrochelatase is **inhibited by excess iron** — this prevents accumulation of heme when iron stores are high and protects against iron-induced oxidative damage. **High-Yield:** ALA synthase is the primary control point: - Inhibited by heme (end-product inhibition) - Inhibited by hemin (oxidized heme) - Induced by drugs (barbiturates, sulfonamides) — explains why these precipitate acute porphyrias - Requires pyridoxal phosphate (B₆) as essential cofactor **Clinical Pearl:** Lead poisoning inhibits ferrochelatase and δ-ALA dehydratase, causing accumulation of δ-ALA and coproporphyrin III in urine ("lead lines" on gums, basophilic stippling of RBCs). ### Why the Distractor Is Plausible The statement about ferrochelatase is written to mirror the activation pattern seen with other biosynthetic enzymes, making it a common conceptual trap. However, ferrochelatase regulation is **inhibitory** to prevent iron toxicity. [cite:Lehninger Principles of Biochemistry 8e Ch 26]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.